feed,title,long_url,short_url
MarketWatch,Sarepta stock rises after FDA approves biotech's Duchenne MD treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/VYJrySkGo5g/story.aspx,https://on.mktw.net/3kqvvSU
